Thalassemia Kids' growth under microscope: new study eyes hidden risks
NCT ID NCT07509996
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at children with beta-thalassemia major, a genetic blood disorder requiring lifelong transfusions. Researchers will measure growth and check for risk factors like iron overload that may stunt development. No new treatment is given—just careful observation of 85 children to understand what affects their growth.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could identify key risk factors for growth problems in children with thalassemia, pointing toward better monitoring or supportive care strategies.
- What could go wrong
- This is an observational study with no treatment being tested, so it cannot directly improve outcomes. Results may not apply to other hospitals or populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THALASSEMIA MAJORS (BETA-THALASSEMIA MAJOR) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.